Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB1518 in advanced lymphoid malignancies
NCT01263899Phase 2Completed
- Sponsor
- S*BIO
- Start
- Dec 2010
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pacritinib in Hodgkin lymphoma (HL), mantle cell lymphoma (MCL), follicular lymphoma (FL), Lymphoplasmacytic Lymphoma (LPL), marginal zone lymphoma (MZL), sponsored by S*BIO. Started Dec 2010; status: completed.
02
Drugs
pacritinib
03
Conditions
Hodgkin lymphoma (HL)mantle cell lymphoma (MCL)follicular lymphoma (FL)Lymphoplasmacytic Lymphoma (LPL)marginal zone lymphoma (MZL)
Beyond the preview
Go deeper on NCT01263899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01263899.